Consenso uruguayo de manejo del infarto agudo de ... - SciELO

In Coronary Thrombolysis(APRICOT)-2 Trial. Circulation 2002; 106: 659-
65.
114. Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H.
Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002;
347: 969-74.
115. Fiore LD, Ezekowitz MD, Brophy MT, Lu D, Sacco J, Peduzzi P,
for the Combination Hemotherapy and Mortality Prevention (CHAMP)
Study Group. Department of Veterans Affairs Cooperative Studies
Program Clinical Trial comparing combined warfarin and aspirin with
aspirin alone in survivors of acute myocardial infarction: primary results of
the CHAMPstudy. Circulation 2002; 105: 557-63.
116. Vaitkus PT, Barnathan ES. Embolic potential, prevention and
management of mural thrombus complicating anterior myocardial
infarction: a meta-analysis. J Am Coll Cardiol 1993; 22: 1004-9.
117. van-den-Berghe G, Wouters P, Weekers F, Verwaest C,
Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill
patients. N Engl J Med 2001; 345: 1359-67.
118. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M,
Bailey VA, et al. Implementation of a safe and effective insulin infusion
protocol in a medical intensive care unit. Diabetes Care 2004; 2: 461-7.
119. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy
SA, de-Lemos JA, et al. TIMI risk score for ST-elevation myocardial
infarction, A convenient, bedside, clinical score for risk assessment at
presentation: An intravenous nPA for treatment of infarcting myocardium
early II trial substudy. Circulation 2000; 102(17): 2031-7.
120. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO-I
Investigators. Predictors of 30-day mortality in the era of reperfusion for
acute myocardial infarction: results from an international trial of 41,021
patients. Circulation 1995; 91: 1659-68.
121. Killip T, Kimball JT. Treatment of myocardial infarction in a
coronary care unit: a two-year experience with 250 patients. Am J Cardiol
1967; 20: 457-64.
122. Guidelines 2000 for cardiopulmonary resuscitation and emergency
cardiovascular care: part 7 the era of reperfusion: section 1acute coronary
syndromes (acute myocardial infarction). Circulation 2000; 102: I172-203.
123. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B,
et al. Eplerenone, a selective aldosterone blocker, in patients with left
ventricular dysfunction after myocardial infarction. N Engl J Med 2003;
348: 1309-21.
124. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et
al. The effect of spironolactone on morbidity and mortality in patients with
severe heart failure: Randomized Aldactone Evaluation Study Investigators.
N Engl J Med 1999; 341: 709-17.
125. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the